Brian Kingwell is a partner in the Vancouver office, practising in the firm's global Intellectual Property and Life Sciences groups.
For over 25 years, his practice has focused on patent prosecution, strategic patent portfolio counselling and due diligence in the areas of molecular biology, genomics, biochemistry, chemistry, chemical engineering and medical devices. Brian advises innovative clients across a range of sectors and industries, including health care, biotechnology, agriculture and cleantech.
He has wide-ranging experience in obtaining patents for innovative products, examples of which include: a novel family of heterocyclic antibiotics, the InsectSelect™ protein expression vector, high oleic acid brassica juncea plants, heavy metal waste remediation processes and Glybera®, the first human gene therapeutic approved in Europe. Brian is also the inventor of a patented medical device, the PeriPatch™ Sleeve.
The common thread across this range of experience is a creative and resourceful approach to maximizing the benefits of intellectual property for clients, helping clients to recognize risks and capitalize on opportunities.
Brian is a registered patent agent in both Canada and the United States.
Year Joined Firm: 1993
Education/Alumni: University of Ottawa LL.B. (cum laude); University of Calgary M.Sc. (Molecular Cell Biology); research focused on chromosome structure and the molecular basis of autoimmune disease; University of Calgary B.Sc. (Biochemistry)
